Values as of: 2024-06-16
COMMON STOCK | Asset Management |
Last Closing
USD 3.57Change
0.00 (0.00)%Market Cap
USD 169.19BVolume
0.01MAnalyst Target
N/AVerdict
Verdict
Currency: USD
Country : UK
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| FP:LSE | Fondul Proprietatea S.A. GDR |
N/A |
USD 264.18B |
| BPCR:LSE | BioPharma Credit PLC |
-0.01 (-0.71%) |
USD 103.14B |
| MNTN:LSE | Schiehallion Fund Ltd |
+0.06 (+6.32%) |
USD 92.77B |
| TFG:LSE | Tetragon Financial Group Ltd |
N/A |
USD 83.64B |
| RTW:LSE | RTW Venture Fund Ltd |
-0.01 (-0.65%) |
USD 53.54B |
| TPOU:LSE | Third Point Investors Limited |
+0.50 (+2.27%) |
USD 53.53B |
| SHIP:LSE | Tufton Oceanic Assets Ltd |
-0.01 (-0.83%) |
USD 35.22B |
| TMI:LSE | Taylor Maritime Investments Lt.. |
+0.01 (+0.51%) |
USD 32.69B |
| III:LSE | 3I Group PLC |
-18.00 (-0.58%) |
USD 30.38B |
| FAIR:LSE | Fair Oaks Income Limited |
+0.01 (+1.82%) |
USD 23.68B |
N/A
| Market Performance vs. Industry/Classification (Asset Management) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | -5.31% | 27% | F | 25% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -5.31% | 28% | F | 25% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | -10.75% | 25% | F | 24% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -10.75% | 26% | F | 24% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | -86.68% | 4% | F | 4% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -86.68% | 4% | F | 4% | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | -11.69% | 11% | F | 13% | F | ||
| Dividend Return | -11.69% | 10% | F | 12% | F | ||
| Total Return | N/A | N/A | N/A | N/A | N/A | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 48.53% | 38% | F | 19% | F | ||
| Risk Adjusted Return | -24.09% | 21% | F | 28% | F | ||
| Market Capitalization | 169.19B | 100% | F | 93% | A | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
The company had negative total cash flow in the most recent four quarters.
